Replies to post #83573 on Biotech Values

[DewDiligence]

MNTA:

…I think it unlikely that doctors will switch to [generic Lovenox] quickly. They will write “do not substitute” initially. Doctors are conservative by nature and training . Since the whole idea of bio identical is so new they won't trust it in the beginning…

Welcome to the board, mauser.

I respectfully disagree with your contention above. In all likelihood, generic Lovenox will have a lower patient co-pay than branded Lovenox in most insurance plans and formularies. I doubt that many docs would opt to bar generic substitution explicitly despite knowing that they would be subjecting patients to a higher medical bill than necessary.

If I’m wrong and it turns out that many docs do check the “do not substitute” box on their Lovenox prescriptions, NVS has ample resources to rectify the situation. Regards, Dew